Comprehensive analysis of mRNA‐level and miRNA‐level subpathway activities for identifying robust ovarian cancer prognostic signatures-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comprehensive analysis of mRNA‐level and miRNA‐level subpathway activities for identifying robust ovarian cancer prognostic signatures

Published:2020-01-19 Issue:4 Volume:24 Page:2582-2592
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Tian Songyu¹,Mi Wanqi²,Zhang Mingyue³,Xing Linan¹,Zhang Chunlong²^ORCID

Affiliation:

1. Department of Gynecological Oncology Harbin Medical University Cancer Hospital Harbin China

2. College of Bioinformatics Science and Technology Harbin Medical University Harbin China

3. Department of Anesthesiology Harbin Medical University Cancer Hospital Harbin China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.14968

Reference42 articles.

1. Ovarian cancer statistics, 2018

2. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

3. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

4. Metazoan MicroRNAs

5. nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP